Arsenate-induced maternal glucose intolerance and neural tube defects in a mouse model

Toxicology and Applied Pharmacology

Volumn 239, Issue 1, 2009, Pages 29-36

  Hill, Denise S ^a   Wlodarczyk, Bogdan J ^a   Mitchell, Laura E ^a,b   Finnell, Richard H ^a,b  

^a TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

Author keywords

Arsenate; Arsenic; Glucose intolerance; Insulin resistance; Mouse; Neural tube defect; Oxidative stress; Teratogen

Indexed keywords

ACETYLCYSTEINE; ARSENIC ACID; GLUCOSE; INSULIN; METHIONINE; N TERT BUTYL ALPHA PHENYLNITRONE; SELENATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; EMBRYO; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HORMONE ACTION; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESISTANCE; MALE; MOUSE; NERVOUS SYSTEM DEVELOPMENT; NEURAL TUBE DEFECT; NONHUMAN; TERATOGENICITY;

ANIMALS; ARSENATES; BLOOD GLUCOSE; DISEASE MODELS, ANIMAL; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; INSULIN; MATERNAL EXPOSURE; MICE; MICE, INBRED STRAINS; NEURAL TUBE DEFECTS; PREGNANCY; PREGNANCY OUTCOME;

ANIMALIA; MUS;

EID: 67650660619     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2009.05.009     Document Type: Article

References (57)

1. Anonymous, 2004. Some drinking-water disinfectants and contaminants, including arsenic. Monographs on chloramine, chloral and chloral hydrate, dichloroacetic acid, trichloroacetic acid and 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone. IARC Monogr. Eval. Carcinog. Risks Hum. 84 (2004) 269-477
2. Anonymous, 2007. Diagnosis and classification of diabetes mellitus. Diabetes Care 30 Suppl. 1 (2007) S42-S47
3. Anonymous, 2007. Standards of medical care in diabetes-2007. Diabetes Care 30 Suppl. 1 (2007) S4-S41
4. Aberg A., Westbom L., and Kallen B. Congenital malformations among infants whose mothers had gestational diabetes or preexisting diabetes. Early Hum. Dev. 61 (2001) 85-95
5. Becerra J.E., Khoury M.J., Cordero J.F., and Erickson J.D. Diabetes mellitus during pregnancy and the risks for specific birth defects: a population-based case-control study. Pediatrics 85 (1990) 1-9
6. Boquist L., Boquist S., and Ericsson I. Structural beta-cell changes and transient hyperglycemia in mice treated with compounds inducing inhibited citric acid cycle enzyme activity. Diabetes 37 (1988) 89-98
7. Buhimschi I.A., Buhimschi C.S., and Weiner C.P. Protective effect of N-acetylcysteine against fetal death and preterm labor induced by maternal inflammation. Am. J. Obstet. Gynecol. 188 (2003) 203-208
8. Cederberg J., Basu S., and Eriksson U.J. Increased rate of lipid peroxidation and protein carbonylation in experimental diabetic pregnancy. Diabetologia 44 (2001) 766-774
9. Coronado-Gonzalez J.A., Del Razo L.M., Garcia-Vargas G., Sanmiguel-Salazar F., and Escobedo-de la Pena J. Inorganic arsenic exposure and type 2 diabetes mellitus in Mexico. Environ. Res. 104 (2007) 383-389
10. Devesa V., Adair B.M., Liu J., Waalkes M.P., Diwan B.A., Styblo M., and Thomas D.J. Arsenicals in maternal and fetal mouse tissues after gestational exposure to arsenite. Toxicology 224 (2006) 147-155
11. Franco G., Malamani T., and Piazza A. Glucose tolerance and occupational exposure to carbon disulphide. Lancet 2 (1978) 1208
12. Golub M.S., Macintosh M.S., and Baumrind N. Developmental and reproductive toxicity of inorganic arsenic: animal studies and human concerns. J. Toxicol. Environ. Health B Crit. Rev. 1 (1998) 199-241
13. Hanlon D.P., and Ferm V.H. Placental permeability of arsenate ion during early embryogenesis in the hamster. Experientia 33 (1977) 1221-1222
14. Hansen J.M. Oxidative stress as a mechanism of teratogenesis. Birth Defects Res. C Embryo Today 78 (2006) 293-307
15. Hill, D.S., Wlodarczyk, B.J., Finnell, R.H., 2008. Reproductive consequences of oral arsenate exposure during pregnancy in a mouse model. Birth Defects Res. B Dev. Reprod. Toxicol. 83 (1), 40-47.
16. Hood R.D., Vedel-Macrander G.C., Zaworotko M.J., Tatum F.M., and Meeks R.G. Distribution, metabolism, and fetal uptake of pentavalent arsenic in pregnant mice following oral or intraperitoneal administration. Teratology 35 (1987) 19-25
17. Izquierdo-Vega J.A., Soto C.A., Sanchez-Pena L.C., De Vizcaya-Ruiz A., and Del Razo L.M. Diabetogenic effects and pancreatic oxidative damage in rats subchronically exposed to arsenite. Toxicol. Lett. 160 (2006) 135-142
18. Izzotti A., Balansky R.M., Camoirano A., Cartiglia C., Longobardi M., Tampa E., and De Flora S. Birth-related genomic and transcriptional changes in mouse lung. Modulation by transplacental N-acetylcysteine. Mutat. Res. 544 (2003) 441-449
19. Janssen P.A., Rothman I., and Schwartz S.M. Congenital malformations in newborns of women with established and gestational diabetes in Washington State, 1984-91. Paediatr. Perinat. Epidemiol. 10 (1996) 52-63
20. Kasapinovic S., McCallum G.P., Wiley M.J., and Wells P.G. The peroxynitrite pathway in development: phenytoin and benzo[a]pyrene embryopathies in inducible nitric oxide synthase knockout mice. Free Radic. Biol. Med. 37 (2004) 1703-1711
21. Kawaguchi I. Studies on As2O3-induced hyperglycemia (author's transl). Nippon Yakurigaku Zasshi 78 (1981) 213-222
22. Knowler W.C., Barrett-Connor E., Fowler S.E., Hamman R.F., Lachin J.M., Walker E.A., and Nathan D.M. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N. Engl. J. Med. 346 (2002) 393-403
23. Kostraba J.N., Gay E.C., Cai Y., Cruickshanks K.J., Rewers M.J., Klingensmith G.J., Chase H.P., and Hamman R.F. Incidence of insulin-dependent diabetes mellitus in Colorado. Epidemiology 3 (1992) 232-238
24. Lai M.S., Hsueh Y.M., Chen C.J., Shyu M.P., Chen S.Y., Kuo T.L., Wu M.M., and Tai T.Y. Ingested inorganic arsenic and prevalence of diabetes mellitus. Am. J. Epidemiol. 139 (1994) 484-492
25. Li, R., Thorens, B., Loeken, M.R., 2007. Expression of the gene encoding the high-K (m) glucose transporter 2 by the early postimplantation mouse embryo is essential for neural tube defects associated with diabetic embryopathy. Diabetologia 50 (3), 682-689.
26. Lindgren A., Danielsson B.R., Dencker L., and Vahter M. Embryotoxicity of arsenite and arsenate: distribution in pregnant mice and monkeys and effects on embryonic cells in vitro. Acta Pharmacol. Toxicol. (Copenh) 54 (1984) 311-320
27. Loeken M.R. Current perspectives on the causes of neural tube defects resulting from diabetic pregnancy. Am. J. Med. Genet. C Semin. Med. Genet. 135 (2005) 77-87
28. Loeken M.R. Advances in understanding the molecular causes of diabetes-induced birth defects. J. Soc. Gynecol. Investig. 13 (2006) 2-10
29. Longnecker M.P., and Daniels J.L. Environmental contaminants as etiologic factors for diabetes. Environ. Health Perspect. 109 Suppl. 6 (2001) 871-876
30. Longnecker M.P., and Michalek J.E. Serum dioxin level in relation to diabetes mellitus among Air Force veterans with background levels of exposure. Epidemiology 11 (2000) 44-48
31. Magalhaes A. Arsenic. An environmental problem limited by solubility. Chem. Pure Appl. Chem. 74 (2002) 1843-1850
32. McLeod L., and Ray J.G. Prevention and detection of diabetic embryopathy. Community Genet. 5 (2002) 33-39
33. Mitchell L.E. Epidemiology of neural tube defects. Am. J. Med. Genet. C Semin. Med. Genet. 135 (2005) 88-94
34. Morrissey R.E., and Mottet N.K. Arsenic-induced exencephaly in the mouse and associated lesions occurring during neurulation. Teratology 28 (1983) 399-411
35. Navas-Acien A., Silbergeld E.K., Pastor-Barriuso R., and Guallar E. Arsenic exposure and prevalence of type 2 diabetes in US adults. JAMA 300 (2008) 814-822
36. Navas-Acien A., Silbergeld E.K., Streeter R.A., Clark J.M., Burke T.A., and Guallar E. Arsenic exposure and type 2 diabetes: a systematic review of the experimental and epidemiological evidence. Environ. Health Perspect. 114 (2006) 641-648
37. Nulton-Persson A.C., and Szweda L.I. Modulation of mitochondrial function by hydrogen peroxide. J. Biol. Chem. 276 (2001) 23357-23361
38. Ortsater H., Liss P., Akerman K.E., and Bergsten P. Contribution of glycolytic and mitochondrial pathways in glucose-induced changes in islet respiration and insulin secretion. Pflugers Arch. 444 (2002) 506-512
39. Parman T., Wiley M.J., and Wells P.G. Free radical-mediated oxidative DNA damage in the mechanism of thalidomide teratogenicity. Nat. Med. 5 (1999) 582-585
40. Paul D.S., Hernandez-Zavala A., Walton F.S., Adair B.M., Dedina J., Matousek T., and Styblo M. Examination of the effects of arsenic on glucose homeostasis in cell culture and animal studies: development of a mouse model for arsenic-induced diabetes. Toxicol. Appl. Pharmacol. 222 (2007) 305-314
41. Pi J., Bai Y., Zhang Q., Wong V., Floering L.M., Daniel K., Reece J.M., Deeney J.T., Andersen M.E., Corkey B.E., and Collins S. Reactive oxygen species as a signal in glucose-stimulated insulin secretion. Diabetes 56 (2007) 1783-1791
42. Rahman M., and Axelson O. Diabetes mellitus and arsenic exposure: a second look at case-control data from a Swedish copper smelter. Occup. Environ. Med. 52 (1995) 773-774
43. Rahman M., Wingren G., and Axelson O. Diabetes mellitus among Swedish art glass workers-an effect of arsenic exposure?. Scand. J. Work Environ. Health 22 (1996) 146-149
44. Rahman M., Tondel M., Ahmad S.A., and Axelson O. Diabetes mellitus associated with arsenic exposure in Bangladesh. Am. J. Epidemiol. 148 (1998) 198-203
45. Ray J.G., O'Brien T.E., and Chan W.S. Preconception care and the risk of congenital anomalies in the offspring of women with diabetes mellitus: a meta-analysis. Qjm 94 (2001) 435-444
46. Rosenn B., Miodovnik M., Combs C.A., Khoury J., and Siddiqi T.A. Glycemic thresholds for spontaneous abortion and congenital malformations in insulin-dependent diabetes mellitus. Obstet. Gynecol. 84 (1994) 515-520
47. Rust D.M., and Soignet S.L. Risk/benefit profile of arsenic trioxide. Oncologist 6 Suppl. 2 (2001) 29-32
48. Sakamaki H., Akazawa S., Ishibashi M., Izumino K., Takino H., Yamasaki H., Yamaguchi Y., Goto S., Urata Y., Kondo T., and Nagataki S. Significance of glutathione-dependent antioxidant system in diabetes-induced embryonic malformations. Diabetes 48 (1999) 1138-1144
49. Shepard T.H., Tanimura T., and Park H.W. Glucose absorption and utilization by rat embryos. Int. J. Dev. Biol. 41 (1997) 307-314
50. Shepard T.H., Muffley L.A., and Smith L.T. Ultrastructural study of mitochondria and their cristae in embryonic rats and primate (N. nemistrina). Anat. Rec. 252 (1998) 383-392
51. Stolzer B.L., Miller G., White W.A., and Zuckerbrod M. Post-arsenical obstructive jaundice complicated by xanthomatosis and diabetes mellitus. Am. J. Med. 9 (1950) 124-132
52. Viana M., Aruoma O.I., Herrera E., and Bonet B. Oxidative damage in pregnant diabetic rats and their embryos. Free Radic. Biol. Med. 29 (2000) 1115-1121
53. Wells P.G., Kim P.M., Laposa R.R., Nicol C.J., Parman T., and Winn L.M. Oxidative damage in chemical teratogenesis. Mutat. Res. 396 (1997) 65-78
54. Widness J.A., Goldman A.S., Susa J.B., Oh W., and Schwartz R. Impermeability of the rat placenta to insulin during organogenesis. Teratology 28 (1983) 327-332
55. Winn L.M., and Wells P.G. Evidence for embryonic prostaglandin H synthase-catalyzed bioactivation and reactive oxygen species-mediated oxidation of cellular macromolecules in phenytoin and benzo[a]pyrene teratogenesis. Free Radic. Biol. Med. 22 (1997) 607-621
56. Wlodarczyk B., Spiegelstein O., Gelineau-van Waes J., Vorce R.L., Lu X., Le C.X., and Finnell R.H. Arsenic-induced congenital malformations in genetically susceptible folate binding protein-2 knockout mice. Toxicol. Appl. Pharmacol. 177 (2001) 238-246
57. Wlodarczyk, B.J., Cabrera, R.M., Hill, D.S., Bozinov, D., Zhu, H., Finnell, R.H., 2006. Arsenic-induced gene expression changes in the neural tube of folate transport defective mouse embryos. Neurotoxicology 27 (4), 547-557.